Skip to main content
Clinical Trials/CTRI/2025/02/081150
CTRI/2025/02/081150
Not yet recruiting
Phase 2

Role of Homoeopathic Medicine in Anaemia using Boenninghausen Characteristics and Repertory by C M Boger- A Single Arm Prospective Clinical Study

National Institute of Homoeopathy1 site in 1 country40 target enrollmentStarted: February 22, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
Hb%

Overview

Brief Summary

Anaemia is condition in which the number of red blood cell or the hemoglobin concentration within them is lower than the normal which cause easily Fatigue, shortness of breath, palpitation, vertigo, headache etc. if not treated can cause serious issue on health and development.

  1. Sample will be selected following preliminary and detailed screening using selected criteria.

  2. Inclusion and exclusion criteria will be strictly follow.

  3. After consideration of drops-out cases a minimum 40 cases will be enrolled for the study.

  4. Case-taking will be done as per the strict homoeopathic principle.

  5. Baseline scoring will be taken using Hb% and FSS.

  6. Analysis and evaluation of each cases will be done.

  7. Miasmatic analysis will be done.

  8. Repertorization will be done by using Boenninghausen Characteristic and Repertory.

  9. Final selection of the remedy will be done after consultation with Materia Medica.

  10. Potency, Doses and Repetition of the indicated remedies will be guided strictly as per homoeopathic principle.

  11. General( non-medical) management including appropriate diet and regimen will be advised.

  12. Subsequent prescription (follow-up) will be generated according to relevant homoeopathic principle and will be recorded in the follow-up sheet

  13. The baseline data will be compared with the data obtained after  6th months.

  14. the score obtained will be compared and the result will be analyzed as per statistical methods and interference will be done thereafter.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients suffering from anaemia, with hemoglobin level between 7g/dl -12g/dl Patients of all socio-economic status and religions.
  • Patients willing to give consent to participating in the study.

Exclusion Criteria

  • Patients having Hemoglobin level less than 7gm/dl Patients with early functional changes like any cause of trauma or injury due to which blood loss or low Hb% occur.
  • Patients with other diagnosed cases of anaemia viz.
  • sickle cell anaemia, thalassemia, aplastic anaemia, hemolytic anaemia etc.
  • Patients suffering from chronic kidney disease, malignancy and heart disease etc.
  • patients who are on substance abuse or dependence.
  • Patients already taking homeopathic medicine for any chronic diseases.
  • Pregnant and lactating women.
  • Patients suffering from unstable mental or psychiatric illness or other uncontrolled or life-threatening illness.

Outcomes

Primary Outcomes

Hb%

Time Frame: Baseline and 6 months

Secondary Outcomes

  • Fatigue Severity Scale(Baseline and 6 months)

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Mem Perme

National Institute of Homoeopathy

Study Sites (1)

Loading locations...

Similar Trials